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Abstract  
Aims: Determining how obesity affects function in human myometrial arteries, to help 
understand why childbirth has poor outcomes in obese women. 
Methods:  Myometrial arteries were studied from 84 biopsies. Contraction (vasopressin and 
U-46619) and relaxation (carbachol, bradykinin, SNAP) was assessed using wire myography. 
eNOS activity was assessed using L-NAME. Cholesterol was reduced using methyl-β-
cyclodextrin to determine whether it altered responses. Differences in endothelial cell 
intracellular Ca2+ signalling were assessed using confocal microscopy. 
Results:  The effects of BMI on relaxation were agonist specific and very marked; all vessels, 
irrespective of BMI, relaxed to bradykinin but 0% of vessels (0/13) from obese women 
relaxed to carbachol, compared to 59% (10/17) from normal weight women. Cholesterol-
lowering drugs did not restore carbachol responses (n=6). All vessels, irrespective of BMI, 
relaxed when NO was directly released by SNAP (n=19). Inhibition of eNOS with L-NAME 
had a significant effect in normal but not overweight/obese vessels.  Compared to bradykinin, 
a lower proportion of endothelial cells responded to carbachol and the amplitude of the 
calcium response was significantly less, in all vessels. Furthermore, a significantly lower 
proportion of endothelial cells responded to carbachol in the overweight/obese group 
compared to control. In contrast to relaxation, the effect of contractile agonists was 
unchanged with increasing BMI.  
Conclusions: The ability of human myometrial arteries to relax is significantly impaired with 
obesity, and our data suggest this is due to a deficit in endothelial calcium signalling. This 
inability to recover following compression during contractions, might contribute to poor 
labours in obese women.  
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Introduction 
According to the World Health Organisation, worldwide obesity rates have more than 
doubled since 1980, showing 39% of adults aged 18 years and over to be overweight and 
13% obese.1 Similarly raised levels of obesity are observed in pregnant women registering for 
antenatal care,2-4 with Iverson and co-workers5 showing a 16.4% increase in obesity in 
pregnant women from 2004 to 2012. In 2006, the incidence of obesity in the pregnant 
population of Liverpool was 17.7%.3 Similar values were observed in the Irish pregnant 
population6 and recent data from the USA7, 8 found the incidence of obesity in the pregnant 
population to be even higher (20.6% and 27.8% respectively). Maternal obesity (BMI≥30) is 
a well-recognised risk factor for difficult pregnancies and adverse outcomes, such as 
hypertension, pre-eclampsia, post-dates, still birth, congenital abnormalities, aberrant fetal 
growth, gestational diabetes and intervention in labour (C-section, induction).3, 4, 9, 10  
 
A healthy pregnancy depends on the maternal cardiovascular system and uterine vasculature 
undergoing complex physiological adaptations.11 During labour, contraction of the 
myometrium exerts external pressure on myometrial blood vessels, causing partial or total 
occlusion.12-15 This leads to repeated transient bouts of myometrial hypoxia. Larcombe-
McDouall and co-workers16 showed that in a rat in vivo model, uterine contraction led to 
reduced blood flow, resulting in altered metabolite levels (decreased ATP and 
phosphocreatine, increased inorganic phosphate) and a decreased intracellular pH (pHi).  
Other in vitro assays have shown uterine pHi to fall during hypoxia or metabolic inhibition 
and if prolonged, to lead to reduced myometrial contractility.17-19  Recently however it has 
been shown that shorter, repeated periods of hypoxia, can actually trigger increases in force 
in the uterus, a mechanism known as HIFI, hypoxia-induced force increase.20  Thus uterine 
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tissue in labour is critically dependent upon its environment, which in turn, depends upon 
blood flow and the myometrial blood vessels. These vessels however have been little studied. 
 
The removal of the metabolites of oxidative stress and intracellular acidification from one 
contraction to the next requires the occluded vessels to dilate and reperfusion of the tissue to 
occur.  This process of perfusion, and vessel dilation occurs hundreds of time over the course 
of labours. If myometrial vessels in obese women are compromised or less resilient, then 
perfusion will decrease and recovery from occlusions will be incomplete. This will change 
the environment surrounding the myofibrils. It is known that lactate will increase and the 
associated decrease in pH can reduce myometrial contractions.21 The HIFI mechanism may 
also be impaired. For these reasons, the increase in adverse pregnancy outcomes experienced 
by obese women may be related to myometrial blood vessel function.  
 
Obesity is associated with alterations in vascular function. In particular endothelial 
dysfunction, frequently caused by deficits in the nitric oxide (NO) system, and hypertension 
are common findings in the obese population worldwide.22  In addition, vascular reactivity, 
that is dilation and constriction responses, are compromised.  As noted above, labour with its 
repetitive episodes of vascular occlusions, will result in stress on the myometrial 
vasculature’s reactivity.  Endothelial dysfunction is associated with pregnancy complications, 
most notably, pre-eclampsia.23, 24 Myometrial vessels from women with pre-eclampsia have 
been shown to lose endothelial-dependent relaxation.25 Work by Myers et al.26 found that 
even in women without pregnancy complications, high BMI attenuated endothelium-
dependent relaxation. Furthermore, a recent study has indicated that signalling in vessels 
from obese women differs from that in vessels from non-obese women.27  
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We have studied human myometrial vessels to better understand their physiology and 
pathophysiology and how obesity contributes to complications in labour. Our focus has been 
on endothelial function and the effects and mechanisms whereby obesity can alter this. Our 
aims therefore were to examine whether maternal BMI affects the ability of the human 
myometrial arteries to contract and to relax in vitro. We have investigated the underlying 
causes of alterations in function in several ways: i) We have used the cholesterol sequestering 
agent, methyl-β-cyclodextran (MCD) to determine whether dyslipidaemia (elevated 
cholesterol) was contributing to any dysfunction. ii) We have used L-NAME to inhibit eNOS, 
in order to determine if there is a deficit in the endothelial NO system as BMI increases and 
iii) we have examined smooth muscle function by using SNAP to directly generate NO and 
bypass the endothelial cell NO production. iv) A rise in intracellular Ca2+ is required in 
endothelial cells in order to activate eNOS and generate NO. Therefore, we have also used 
confocal microscopy to examine whether the calcium signalling of myometrial artery 
endothelial cells is altered with increasing maternal BMI. 
 
Results 
Baseline characteristics. 
Data were obtained on 84 singleton pregnancies with biopsies obtained during elective C-
sections after otherwise uncomplicated term pregnancies. The reason for C-section (CS) and 
mean data for maternal age, body mass index (BMI), parity, gestational age and weight of the 
baby is shown in Table 1. As expected, there is a significant difference in BMI between all 
groups. Median gestational dates were longer (by one day) in the overweight group. 
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 Normal weight 
(n=35) 
Overweight 
(n=27) 
Obese 
(n=22) 
P value 
Maternal age 
(years)  
32 (29-37) 34 (29-37) 30.5 (27.75-35.5) 0.31 
Maternal 
BMI (kg/m2) 
23 (22.2-23.6) 27.3 (26.0-27.8) 34.4 (31.1-37.5) <0.0001 
Parity 1 (0 – 5) 1 (0 - 3) 1 (0 - 3) 0.19 
Gestational 
age (days) 
273 (267.8-275) 274.5 (273-276) 273 (269.5-274.5) 0.003 
Birth weight 
(grams) 
3325 (3058-3563) 3590 (3300-3890) 3460 (2980-3770) 0.04* 
Reason for CS     
Previous CS, 
n (%) 
20 (57.1%) 15 (55.6%) 13 (59.1%)  
Previous 
difficult birth, 
n (%) 
5 (14.3%) 5 (18.5%) 2 (9.1%)  
Breech, n (%) 3 (8.6%) 3 (11.1%) 1 (4.5%)  
Other, n (%) 7 (20%) 4 (14.8%) 6 (27.3%)  
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Table 1. Maternal demographic and obstetric data for the women participating in this study; 
data expressed as median (IQR) or number n (%). Parity is expressed as median (range). 
Maternal BMI was measured at the booking appointment. * Kruskal-Wallis test p=0.04 but 
Dunn’s multiple comparison post-hoc test did not find a difference between groups. 
 
Contractility assays 
Mean vessel diameter was 354.7±9.9µm, with a range from 160 to 680µm. There were no 
statistical differences in vessel size for any experimental group described below. Data is 
divided into 3 BMI groups; normal weight (BMI<25), overweight (BMI 25-29.9) and obese 
(BMI≥30). 
Vessels from an additional 7 myometrial biopsies (not included in Table 1) were 
unresponsive to K+ and were thus discarded (3x BMI<25, 4x BMI≥25, these are not included 
in Table 1). In the remaining vessels from 67 biopsies, the magnitude of the response to K+ 
was not significantly different between groups (BMI<25; 0.85 (0.11-2.7) mN/mm, n=28, 
overweight: 0.78 (0.33-2.32) mN/mm, n=21, obese: 0.79 (0.23-1.92) mN/mm, n=18; Mann 
Whitney test p=0.75). 
  
Effect of maternal BMI on contraction 
Two well characterised contractile agonists were studied: the thromboxane A2 analogue, U-
46619 and arginine vasopressin (AVP). 
 
Contraction with U-46619 
Cumulative concentration-response curves to U-46619 (1nM - 3µM) were obtained in 33 
human myometrial biopsies. U-46619 produced a sustained contraction of the myometrial 
arteries (Figure 1A & B). When samples were separated by BMI, there was no significant 
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difference in EC50 between the BMI groups (see Figure 1C: BMI<25 pEC50=7.02±0.19, 
n=12; overweight pEC50=6.64±0.20, n=12; obese pEC50=6.84±0.19, n=7, Kruskal-Wallis test 
p=0.053). The maximum amplitude of the response (normalised to a high K+ response) was 
also unaltered (BMI<25 Max=713.4±122.4%, n=12; overweight Max=675.0±139.5%, n=12; 
obese Max=473.0±96.2%, n=7, Kruskal-Wallis test p=0.54). There was also no significant 
difference in vessel size between groups (BMI<25 380.1 (276.5-484.1) µm; overweight 299.9 
(227.4-359.5) µm; obese 249.7 (227.1-369.2) µm, Kruskal-Wallis test p=0.059). Based on 
these data, a concentration of 1µM U-46619 was chosen to contract vessels for the 
subsequent study of relaxation. 
 
Contraction with arginine vasopressin 
AVP also produced a sustained contraction of the myometrial arteries (Figure 1D & E). 
Cumulative concentration-response curves (0.1nM - 10nM) were obtained in 25 human 
biopsies. There was no significant difference in vessel size between groups (BMI<25; 
420.6±27.8µm; overweight 405.1±56.4µm; obese 347.0±73.1µm, ANOVA p=0.60).When 
samples were separated by BMI, there was no significant difference in EC50 between the BMI 
groups (see Figure 1F: BMI<25 pEC50=8.88±0.20, n=15; overweight  pEC50=8.73±0.26, n=6; 
obese pEC50=9.01±0.24, n=3; ANOVA p=0.60). The maximum response between the two 
groups was not significantly different BMI<25 Max=500.0±87.0%, n=15; overweight 
Max=411.7±115.2%, n=6; obese Max=453.4±105.6%, n=3; ANOVA p=0.89).  
Based on these data, a concentration of 10nM AVP was chosen to contract vessels for the 
subsequent study of relaxation. 
 
 
Effect of maternal BMI on relaxation 
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Endothelium-dependent relaxation: Bradykinin (BK) 
Vessels were pre-contracted with 10nM AVP. Once the contraction had stabilised, a 
concentration-response curve to BK was obtained (1nM – 1µM). All vessels from normal 
weight, overweight and obese women relaxed equally well to BK (BMI<25 
pEC50=7.63±0.23, n=10; overweight pEC50=7.91±0.07, n=7; obese pEC50=7.60±0.08, n=6; 
ANOVA p=0.31, Figure 2A). 
Concentration-response curves to bradykinin were also obtained in vessels pre-contracted 
with 1µM U-46619. Again all vessels relaxed equally well to BK (BMI<25 
pEC50=7.88±0.18, n=15; overweight pEC50=7.46±0.17, n=10; obese pEC50=7.27±0.75, n=5; 
ANOVA p=0.94,Figure 2B). There was no significant difference in the maximum relaxation 
achieved in each BMI group (ANOVA, p=16). The nature of the pre-contractile agent did not 
alter the potency of the BK response, however the amplitude response in the overweight and 
obese groups was significantly smaller when the tissue was precontracted with U-46619 than 
with AVP (Student’s t-test: overweight p=0.046, obese p=0.024).  
 
Endothelium-dependent relaxation: Carbachol (CCh) 
Vessels were pre-contracted with 10nM AVP. Once the contraction had stabilised, the 
response to CCh was obtained. In contrast to BK, not all vessels relaxed when challenged 
with CCh (Figure 3A & B). When samples were separated by BMI, vessels from 10 of 17 
biopsies (59%) from normal weight women responded to CCh (mean inhibition of 
58.6±0.06%), whereas vessels from the remaining 7 biopsies (41%) failed to relax in 
response to CCh (mean inhibition of 6.3±0.02%). There was no significant difference in BMI 
between responders and non-responders (Responders 22.34±0.60; Non-responders 22.9±0.71, 
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unpaired t-test p=0.56) and no significant difference in vessel size (Responders 390.8±36.3 
µm; Non-responders 384.3±30.9 µm, unpaired t-test p=0.91). 
In biopsies from overweight women, vessels from only 4 of 13 biopsies (31%) responded to 
CCh (mean inhibition of 73.0±8.8 %), whereas 9 of 13 (69%) did not relax (mean inhibition 
of 3.0±1.2 %) when stimulated with CCh. Again, there was no significant difference in BMI 
between responders and non-responders (Responders 26.9±0.38; Non-responders 26.2±0.23, 
unpaired t-test p=0.13) and no significant difference in vessel size (Responders 333.9±51.6 
µm; Non-responders 333.5±25.8 µm, unpaired t-test p=0.99). In biopsies from obese women, 
no response to CCh was observed in any of 13 vessels (mean inhibition of 10.0±1.4 %, mean 
vessel size 331.0±26.5). It should be noted however that all of these vessels responded 
normally to BK (Figure 3B). 
 
If we separate the data by response to CCh, then the mean BMI of women whose vessels 
responded to CCh was 23.64±0.72 (n=14), which was significantly lower than those that did 
not respond to CCh 29.33±1.15 (n=29, unpaired t-test p=0.002, Figure 3C). There was no 
significant difference in vessel size (Responders 373.9±28.93 µm; Non-responders 
342.7±16.33 µm, unpaired t-test p=0.32). Concentration-response curves for CCh were 
obtained in responding vessels (Figure 3E), where pEC50=7.27±0.33 (n=6  (of which 5 
normal weight, 1 overweight)). 
In vessels pre-contracted with 1µM U-46619, 10µM CCh produced relaxation in vessels from 
3 of 9 biopsies with BMI<25 and in 0/7 biopsies from women with BMI≥25 (overweight 
n=6, obese n=1). 
 
Endothelium-independent relaxation: SNAP 
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In order to determine if the impaired relaxation was due to signalling changes or impairment 
at the level of the contractile machinery, the NO donor SNAP (20µM) was used to directly 
activate the myometrial artery smooth muscle cells. Application of SNAP produced a rapid 
and complete relaxation of AVP pre-contracted myometrial vessels from all women (BMI<25 
% inhibition=96.8 (95.6-101) %, n=13: overweight % inhibition=97.5 (95.7-101) %, n=10 
biopsies; obese % inhibition=90.9 (90.3-95.6) %, n=9; Dunn’s multiple comparison test 
shows no difference between these groups, Figure 4A & B). When vessels were pre-
contracted with U-46619, again there was no difference in degree of relaxation observed in 
the 3 BMI groups (BMI<25 % inhibition=90.3 (86.3-92.7) %, n=17: overweight % 
inhibition=91.4 (86.7-94.1) %, n=11 biopsies; obese % inhibition=72.0 (62.3-91.5) %, n=4; 
Kruskal-Wallis test p=0.23). 
 
Effect of lowering cholesterol levels with methyl-β-cyclodextrin (MCD) 
Previous data has shown that the dyslipidemic environment often associated with high BMI 
can impair vascular function. 28, 29 We have therefore investigated whether lowering 
cholesterol, by sequestration with MCD, would alter the responsiveness of the human 
myometrial arteries to CCh. This method has previously been shown to reduce the cholesterol 
content of myometrial strips by 50% over a 20min incubation period.30 Vessels from women 
with BMI≥30 consistently failed to respond to CCh. Pre-treatment of vessels with 2% MCD 
to modulate cholesterol (and thus caveolae) did not restore a response to CCh. No response to 
CCh was observed in these vessels from obese women either before or after MCD treatment 
(Control n=6 versus MCD n=6). Additionally, after MCD treatment, the amplitude of the pre-
contraction to AVP (10nM, not shown), the response to SNAP (20µM, not shown) and the 
EC50 and amplitude of the BK concentration-response curve (Figure 4C) were not 
significantly altered. 
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Effect of L-NAME inhibition 
In order to determine whether nitric oxide synthase (NOS) activity is altered in the 
endothelial cells of vessels from women of normal weight and overweight/obese women, the 
response to BK was assessed in the absence and presence of 100µM L-NAME. Since our 
previous experiments demonstrated no significant difference in the response to BK in 
overweight and obese vessels, we have compared BMI<25 vessels with BMI≥25 vessels in 
this experiment. Vessels were pre-contracted with 10nM AVP. The 30min application of L-
NAME caused a significant increase in the amplitude of the contraction in normal weight (% 
increase; Control 2.02±4.9%, n=6 versus L-NAME 26.08±4.6%, n=6; p=0.005) and BMI≥25 
vessels (% increase; Control 4.73±3.7%, n=5 versus L-NAME 27.77±5.3%, n=5; p=0.007, 
see Figure5A & B).  
In vessels from normal weight women, L-NAME caused a significant rightward shift of the 
BK concentration-response curve (BK 7.78±0.28, n=5; BK with L-NAME 7.06±0.20, n=6; 
p=0.023, see Figure 5C) and the maximum relaxation achieved with BK was significantly 
smaller (BK 0.28±0.12; BK with L-NAME 0.57±0.06; p=0.04). In vessels from 
overweight/obese women (BMI≥25), L-NAME did not have a significant effect on the BK 
concentration-response curve (BK 7.88±0.24, n=5; BK with L-NAME 7.93±0.49, n=4; 
Mann-Whitney test p=0.73, see Figure 5D). 
 
Confocal microscopy 
Using confocal microscopy, we examined the endothelial cell layer in myometrial arteries 
that were between 50µm and 1000µm in size, from 22 myometrial biopsies. The endothelium 
was confirmed to be intact following tissue loading and preparation (Figure 6A) and normal 
weight and overweight/obese samples were indistinguishable by eye. In all tissues, BK 
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produced a rise in intracellular Ca2+ in endothelial cells (expressed as a ratio F/F0). This rise 
was of a similar amplitude in vessels in both the normal weight (F/F0 2.49 (2.41-3.03), n=8) 
and BMI≥25 groups (F/F0 3.08 (2.53-3.94), n=9, Mann Whitney test, p=0.24, Figure 6 and 
7A-B). The response was characterised by a large, rapid upstroke of intracellular Ca2+; 
sometimes this response was transient, sometimes it was followed by a sustained plateau 
phase, as seen in Figures 6C and D, respectively. These patterns were exhibited irrespective 
of BMI. 
 
In vessels from normal weight women, a response to 10µM CCh was observed. However the 
amplitude of the Ca2+ response was significantly smaller than that to BK (F/F0: CCh 
1.79±0.20 versus BK2.55±0.16, n=6, paired t-test p=0.013, Figure 7A) and a lower 
proportion of cells responded (CCh 12.3±5.8 % versus BK 78.8±5.4 %, n=9, paired t-test 
p=0.0001, Figure 7C, Video 1).  
In most vessels from women with BMI≥25, only one or two endothelial cells in the field of 
view (or frequently no cells), responded to stimulation with CCh (Figures 6C-D & 7D). The 
amplitude of the CCh response, when it was present, was similar to that seen in vessels from 
normal weight women (unpaired t-test p=0.33, Figures 7A & B), meaning that again the CCh 
response was significantly smaller than the BK response (F/F0: CCh 2.11±0.21 versus BK 
2.97±0.40, n=4, paired t-test p=0.049, Figure 7B). Only 0.4 (0 - 2.2) % of cells responded to 
CCh compared to 91.4 (72.9 – 98.9) % to BK (Wilcoxon signed rank test p<0.004, n=9, 
Figure 7D, Video 2).  A significantly lower percentage of endothelial cells responded to CCh 
in the BMI≥25 group than in the normal weight group (Mann Whitney test p=0.037), whereas 
a similar number of cells responded to BK irrespective of BMI (Mann Whitney test p=0.76). 
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We examined whether SNAP (20µM) generated a Ca2+ response in myometrial artery 
endothelial cells and observed no response in endothelial cells from all BMI groups (n=8, see 
Video 3). 
We also examined the timecourse of the BK endothelial cell Ca2+ response, by comparing the 
time differential between the first and last cells to respond with a rise in intracellular Ca2+ to 
agonist application. No significant difference was observed in the timecourse of the Ca2+ 
response to BK in vessels from normal weight women (21.85±5.8 sec from 1st to last 
response) and overweight/obese women (BMI≥25, 22.04±4.0 sec). The same analysis could 
not be carried out for CCh, as so few cells responded to CCh in the overweight/obese 
preparations. 
These confocal experiments to measure endothelial cell responses were carried out under 
resting conditions, unlike the functional myograph assays, where endothelial responses were 
assessed in the presence of the contractile agonists AVP or U46610. In order to demonstrate 
that the presence of the contractile agonist had no effect on the endothelial cell Ca2+ response, 
we compared the amplitude of the Ca2+ response to BK in the absence and presence of 10nM 
AVP in vessels from normal weight women. No differences were observed (Resting 
conditions F/F0 2.49 (2.41-3.03), n=8; with AVP F/F0 2.78 (2.38-3.22), n=4; Mann Whitney 
test p=0.68) and a similar % of cells responded (Resting conditions 78.8±5.4 %, n=9; with 
AVP 86.6±7.2 %, n=4, p=0.42).  
 
 
Discussion 
Obesity has been consistently associated with vascular dysfunction.31, 32 Obese and 
overweight women have an increased risk of problems in pregnancy and delivery.4, 10 Healthy 
pregnancies and deliveries depend on the maternal cardiovascular system and uterine 
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vasculature undergoing complex physiological adaptations11 and impairment of these 
processes will have significant consequences. Obesity is a significant risk factor for maternal 
and fetal complications, and intervention in labour, especially Caesarean-sections.4, 10 Despite 
this, the vessels within the myometrium have received little attention. Given the clear 
importance of the vasculature to a healthy pregnancy, it is necessary to understand if obesity 
is associated with impairment of the myometrial vessels. As both vascular contraction and 
relaxation are needed for proper functioning, we investigated the effects of obesity on both.  
 
We found a clear relationship between impaired vasorelaxation and increasing BMI, and this 
was an agonist-specific, not a global, effect. All vessels from normal weight, overweight and 
obese women relaxed to bradykinin, but the response to another relaxatory agonist, 
carbachol, decreased with increasing BMI. It is worth emphasising that no vessels from obese 
women responded to carbachol and only a third of vessels from overweight women 
responded. The contractile responses of these vessels did not alter with increasing maternal 
BMI. 
Hayward et al. (2014)27 are the only other group to have studied the effect of maternal BMI 
on myometrial artery function. They reported deficits in specific regulatory pathways in 
vessels from obese women: impaired contraction with U-46619 but not AVP (with no 
concomitant change in TBXA2 receptor expression), impaired relaxation to BK when the 
vessel was pre-contracted with AVP but not U-46619 and similarly, impaired relaxation to 
the NO donor SNP when the vessel was pre-contracted with AVP but not U-46619. The 
magnitude of the deficits were small. In our study, despite similar subjects and experimental 
procedures, we see no effect of BMI on contractile responses and BK-mediated relaxation is 
maintained in overweight and obese groups (no matter which pre-contractant is used). 
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Hayward et al. did not study carbachol. Our data showed a significant deficit in the response 
to carbachol.  
In our hands, direct donation of NO to the vascular smooth muscle results in unimpaired 
relaxation, suggesting that the deficit  is in the endothelial production of NO, rather than the 
ability of the vessel to respond to it. In pregnant human myometrial arteries, BK can generate 
relaxation via activation of the endothelial derived hyperpolarising factor (EDHF) pathway, 
as well as via the NO pathway and in fact both pathways need to be blocked in order to 
inhibit the BK response.33 The results of our L-NAME experiment suggest a deficit in the NO 
system in obese women, since the BK response was sensitive to eNOS inhibition in normal 
weight but not overweight/obese vessels. The BK response however remains intact in these 
vessels presumably because the EDHF pathway can compensate for the loss of NO. 
Carbachol may not be able to activate the EDHF pathway to the same extent, making the 
muscarinic response more susceptible to impairment with obesity. 
 
Obesity, pregnancy and vasculature function 
Obesity is associated with endothelial dysfunction in a range of animal models of diet-
induced obesity,34, 35 as well as obese humans.32, 36, 37 Oxidative stress coupled with 
reductions in NO bioavailability appear to contribute to the endothelial dysfunction in 
obesity.38-40 Although less well studied, it has been found that myocyte function per se is also 
altered in vessels from obese individuals.41, 42 It is likely that other pathways may 
compensate, at least initially, for changes in vascular function with obesity, suggesting that 
some receptors and pathways are more vulnerable to the obese environment; for example in 
coronary arterioles of obese rats, an increased activity of soluble guanylate cyclase leads to 
enhanced sensitivity to NO, which contribute to the maintenance of NO-mediated dilations 
and coronary perfusion.43  
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Obesity in pregnancy, as in non-pregnant individuals, leads to dyslipidemia, impaired 
vascular function and a perturbed metabolic and inflammatory state.26, 44-46 For example, 
Sarno et al. (2015) found that obese women have increased umbilical artery resistance.45 
Similarly, our data in myometrial vessels showed an agonist specific impairment of 
vasorelaxation, impaired NO production by the endothelium, and alterations of endothelial 
calcium signalling, all associated with obesity.  
 
Work conducted to elucidate how obesity affects vascular function, indicates that agonist-
stimulated endothelium-dependent vasodilation is multiply impaired in obesity (see e.g. Van 
Guilder et al.47). Muscarinic dysfunction i.e. responses to ACh, carbachol or methacholine 
were the first receptor signalling pathway to be shown to be affected by obesity. Subsequent 
in vivo work confirmed these findings.  It has been reported that forearm vasodilation 
responses in vivo to ACh in pregnant women is impaired, and that this response develops 
throughout gestation.46 We found impaired vasodilation to carbachol but not bradykinin. In 
an earlier study by Myers et al.48 they failed to demonstrate carbachol relaxation in human 
myometrial arteries, so used bradykinin instead to investigate vasodilation, but no details of 
BMI were given. This suggests the response to carbachol in myometrial arteries is less robust 
than that to bradykinin, which is consistent with our calcium signalling data. There is some 
evidence that oxidative stress, which is a feature of obesity, can cause a reduction in 
expression of M3 receptors.49, 50 More specifically, Lin et al.51 recently showed that a high fat 
diet led to decreased muscarinic M3 receptor expression in rat bladder. A reduction in the 
expression of M3 receptors could account for the decreased relaxation and endothelial cell 
calcium signalling we found in vessels from obese women but further studies would be 
required to confirm this. We can find no evidence for bradykinin B2 receptor expression 
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changes with obesity, and previous functional studies are contradictory, with BK-mediated 
relaxation either impaired with obesity52, 53 or unchanged.54 
 
Confocal microscopy and Calcium signalling. 
We have performed the first confocal analysis of calcium signals in pregnant human 
myometrial artery endothelial cells. We could distinguish endothelial cell Ca2+ signals from 
myocyte signals and could observe intact sheets of endothelial cells and thus be confident that 
the endothelium had not been damaged.29, 55 We show that even in vessels from normal 
weight women, which relax to both carbachol and bradykinin, the amplitude of the 
intracellular Ca2+ response was significantly smaller to carbachol compared with bradykinin 
and a significantly lower proportion of endothelial cells responded. These inhomogeneous 
Ca2+ responses were apparent in vessels from overweight/obese women too and thus are 
independent of BMI. Similar inhomogeneous distribution of endothelial cell responses to 
agonist stimulation has been shown in mouse aorta.56 When we compared responses in 
vessels from overweight and obese women, a significant reduction in the number of 
endothelial cells that respond to carbachol was found. The response to bradykinin in 
endothelial cells from the vessels of overweight and obese women was similar to that in the 
normal weight group. These data, taken alongside our findings on signal amplitude, suggest 
that carbachol Ca2+ signalling in human myometrial arteries, is significantly less robust to the 
effects of an environment changed by obesity, than is bradykinin signalling. In turn, these 
direct measurements of Ca2+ responses also support the functional responses we found, i.e. 
carbachol relaxation is impaired in obesity and bradykinin responses are not. 
 
Vasoconstriction  
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Although there is evidence that vasoconstriction is elevated in obese individuals,57, 58 our data 
in myometrial arterial vessels do not suggest increased tone associated with obesity in 
pregnant women. Using AVP, Hayward et al.27 also reported no difference in vasoconstrictor 
responses with BMI. They also found no difference with U46619 in overweight, compared to 
normal weight women, in agreement with our data. They did however find a small but 
significant difference in the obese group. While we did not find significance, examination of 
our Figure 1C, shows all the data points in the obese women lying beneath those from normal 
weight women. Our data were normalised to K+-depolarization, whereas Hayward et al. 
report pressure values; it may be that this led to the different findings.  
  
Caveolae and cholesterol manipulation 
Our work with ApoE knockout mice, which have elevated cholesterol and LDLs, has shown a 
selective, reduced relaxation to carbachol in aortic preparations compared to wildtype mice.28 
In myometrial myocytes, contractions were increased when cholesterol was lowered.30 It has 
been postulated that because of the dyslipidaemia usually associated with obesity, membrane 
domains and cholesterol-rich membrane caveolae may be altered.59, 60 Of particular note, NO-
synthase (NOS) is inactive in caveolae. It is only as agonists stimulate a rise in Ca2+, which 
binds with calmodulin and this complex interacts with NOS, that it can move to a non-
caveolar location and activate. Dreja et al.61 found that MCD reduced the vasopressin 
response by 50% in rat tail arteries, suggesting V2 receptors are also affected by cholesterol 
and caveaolae. Our data with MCD, to lower cholesterol and reduce caveolae, however, 
showed no improvement in relaxation to carbachol in the human myometrial arteries.  
 
Study limitation and implication 
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Our data come from biopsies from 84 women. While this represents a considerable 
accomplishment in obtaining human samples, nevertheless there will always be concerns how 
representative the group is. We used biopsies from elective sections from women not in 
labour, to reduce variability between groups e.g. length and progress of labour. Thus, any 
effects of labour on the myometrial vessels could not be studied. Our data was also collected 
from women having uncomplicated pregnancies despite being obese; excluding 
complications may mean we are under representing the size of the effects found. 
The vessels were dissected from myometrial biopsies and placed on wire myographs. This 
methodology meant it was impossible to study vessels below approx. 100µm, which may be 
more affected by obesity than the larger arteries. Responses to SNAP confirmed that the 
vessels had not been damaged by dissection and mounting for study. There were also no 
significant differences in the size of vessels with BMI, removing this as a factor influencing 
the results. While we demonstrated a deficiency in the NO system in endothelial cells from 
obese women, we did not measure muscarinic M3 receptor expression and therefore cannot 
discount that changes in receptor number or function could also contribute to the 
dysfunctional relaxation observed. Although MCD has been documented to effectively 
reduce cholesterol in a wide variety of tissues and cells,62 we did not directly determine 
cholesterol levels in this study. 
 
Relation to labour outcome 
As noted earlier, during labour there is repetitive compression of the uterine blood vessels 
and hypoxia and alterations in metabolites.16, 63, 64  Repetitive transient hypoxia can increase 
myometrial contractions, HIFI, and may be a mechanism to counter the metabolic changes.20  
Much less well documented however is how the vascular myocytes themselves are affected 
by the compressions, which will increase as labour progresses. There will be a fall in pHi in 
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the vascular myocytes due to stimulation of glycolysis. This will reduce their ability to 
produce force and relaxation will also be slowed.65  In the myometrium, the removal of the 
metabolites of oxidative stress and intracellular acidification from one contraction to the next, 
requires the occluded vessels to dilate fully.  
Our data show that although the ability to constrict is unaffected by BMI, impaired relaxation 
in the myometrial vessels occurs in obese women; they are compromised and less resilient, 
and thus recovery from occlusions will be incomplete. We suggest this produces a gradual 
change in the environment surrounding the myofibrils, e.g. build-up of lactate that will reduce 
contractions.21 Such a lactate acidosis is associated with dysfunctional labours66 and would 
directly relate to the increase in instrumental delivery experienced by obese women.  
 
Methods  
Non-labouring human myometrial biopsies were collected from 84 women with full term, 
uncomplicated singleton pregnancies undergoing elective caesarian section (median gestation 
39 weeks (range 37+1 to 40+4 weeks)), at Liverpool Women’s Hospital, UK. All women gave 
written informed consent to participate. The study was approved by the North West 
(Liverpool East) Research Ethics committee (Ref: 10/H1002/49) and by the Research and 
Development director at Liverpool Women’s Hospital NHS Foundation Trust, Liverpool, 
UK. Indications for caesarian section were previous caesarian section (48), previous 
traumatic vaginal delivery (12), breech presentation (7) and other reasons (17), such as 
placenta previa, tocophobia, fetal abnormalities and maternal spina bifida or cerebral palsy. 
The average BMI of the women was 32.52 (range 19 – 47) and average weight of the babies 
was 3441g (range 2400 – 4550g). Biopsies were taken from the upper edge of the lower 
uterine segment incision immediately after delivery of the baby.67 All biopsies were placed in 
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Hanks balanced salt solution at 4°C and experiments were performed within 24 hours of 
biopsy excision.  
 
Contractility 
 
Using a stereomicroscope, small myometrial arteries (mean (range): 354.7µm (160-680µm) 
were dissected, cut into 2mm sections and mounted in a DMT dual wire myograph. Vessels 
were maintained in a physiological salt solution (composition (mM): NaCl 154, KCl 5.6, 
MgSO4.7H2O 1.2, HEPES 10.9, glucose 8, and CaCl2 2 (adjusted to pH7.4)) at 35ºC and 
gently bubbled with oxygen. The vessels were set to their normalized diameter according to 
the method of Mulvany and Halpern.68 The aim of normalization is to determine the internal 
circumference the vessel would have if relaxed and under a transmural pressure of 100mmHg 
(L100), with the vessel being set to L1 = 0.9x L100, where active force production has been 
shown to be maximal.  Briefly, vessels were stretched in small increments and passive 
tension was recorded. The vessel was stretched until the passive tension had reached the limit 
of 13.3 kPa (100 mmHg). Vessels were then normalized to an internal circumference 
calculated as 90% of this limit for the remainder of the experiment (0.9 x IC100). Normalized 
lumen diameter is taken as L1/π (as described in ‘Procedures for investigation of small vessels 
using small vessel myograph’, by Mulvaney).69 
Vessels were divided into 3 groups, those from women with a BMI<25 (i.e. normal weight) 
and those with BMI25-29.9 (overweight) and those with BMI≥30 (obese). All tissues were 
challenged with 60mM K+ to test viability. 
23 
 
Vessel contractility was assessed by obtaining cumulative concentration-response curves to 
the agonists arginine vasopressin (AVP, 0.1 – 10nM) and the thromboxane analogue, U-
46619 (1nM – 3µM). The response to each concentration was allowed to reach a plateau 
before the next concentration was applied. To measure relaxation, vessels were pre-
contracted with either 10nM AVP or 1µM U-46619. Once the contractile response had 
stabilised, vessels were challenged with bradykinin (BK, 1nM - 3µM), carbachol (CCh, 1nM 
- 10µM or single concentration of 10µM) or the NO donor, S-nitroso-N-actetyl-DL-
penicillamine (SNAP, 20µM). Again each agonist was applied for as long as required to 
attain a steady state response, or for 10 min if no response was observed. In parallel 
experiments, membrane cholesterol was extracted from vessels (from women with BMI>30) 
using methyl-𝛽-cyclodextrin (MCD), a cyclic oligosaccharide which sequesters cholesterol as 
previously described. 28, 30, 62 Vessels were pre-treated with 2% MCD for 20 min, washed x2 
and equilibrated for 30 min prior to assessing contractility and relaxation.28 L-NAME was 
used to assess the effect of inhibiting nitric oxide synthase (NOS). Vessels were 
precontracted with 10nM AVP. Once the response had stabilised, 100µM L-NAME was 
applied for 30min, after which BK concentration-response curves were obtained. 
 
Confocal microscopy 
Isolated myometrial arteries and strips of myometrium with vessels running through them 
were incubated with 15M Cal-520 for 2.5h at 34ºC, in the presence of 0.25% of the non-
ionic detergent Pluronic F-127. The tissue was then placed in physiological salt solution to 
allow de-esterification of the dye. Vessels and strips were mounted under a small amount of 
isometric tension between two fixed aluminium foil clips at the bottom of the chamber, on the 
stage of an Olympus inverted microscope, as previously described. 28, 29, 55 The chamber was 
perfused with physiological salt solution at a constant flow rate (1ml/min) and maintained at 
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34C. Experiments were performed using an Ultraview LCI spinning (Nipkow) disc, wide-
field confocal microscope (Perkin Elmer, Cambridge, UK), equipped with an Orca ER cooled 
CCD camera (Hamamatsu Photonics, UK) and a 20x objective (N.A. 0.7; see 70). Mean 
fluorescence intensity was measured on-line from regions of interest drawn over individual 
cells using UltraView software. Well-loaded cells were chosen for analysis, with up to 10 
individual cells analysed per tissue strip. Movement artefacts were occasionally a problem, 
however if substantial movement occurred, measurements were not made. The numerical 
data obtained were saved to an ASCII file for further analysis using Origin 7.0 software. The 
amplitude of the [Ca2+]i signal was expressed as a normalised pseudo ratio of Cal-520 
fluorescence (F/F0). Once a stable baseline signal was established, the agonist carbachol was 
applied at 10M and bradykinin at 1M. The resulting Ca2+ signals were measured in terms 
of the peak amplitude of the response and the percentage of cells responding to CCh and 
bradykinin. Similar experiments were carried out in the presence of 10nM AVP. The 
timecourse of BK-mediated calcium responses was assessed by measuring the time difference 
between the first and last cells to respond to the agonist. 
 
Data Analysis 
Contractility data were recorded using LabChart Data Acquisition software (ADInstruments). 
Contractile amplitude of KCl was expressed as mN/mm and other agonist data (AVP, 
U46619) were normalised to the KCl response obtained in that tissue (expressed as % of the 
KCl response). Relaxation is expressed as % reduction of the initial pre-contraction. If 
multiple vessels were obtained from one biopsy, then the data were averaged (n=number of 
biopsies). Concentration-response curves were fitted to the logistic equation using non‐linear 
regression (PRISM, version 5.0; Graph Pad Software Inc., San Diego, CA, USA). Data that is 
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normally distributed is expressed as mean ± s.e.m. and non-parametric data is expressed as 
median (interquartile range). Statistical differences were tested with the Student’s t test, 
Mann Whitney test, ANOVA or Wilcoxon signed rank test as appropriate, using PRISM. 
p < 0.05 was considered statistically significant.  
 
Drugs and solutions 
Unless otherwise specified, chemicals were obtained from Sigma (UK). Pluronic-F127 was 
obtained from Invitrogen, Cal-520 from Stratech Scientific Ltd (UK) and U46619 from 
Cambridge Bioscience (UK). Cal-520 was made up to a stock concentration of 15mM in 
DMSO, and diluted to 15µM in physiological salt solution as required. A SNAP stock 
solution (100mM) was prepared in DMSO and bradykinin (10mM) was prepared in 0.1M 
acetic acid, however the final concentration of DMSO and acetic acid in the myograph bath 
was negligible and no vehicle control was required (0.02% DMSO or 0.00006% acetic acid). 
All other drugs were made up in aqueous solution.  
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Figure legends 
 
Figure 1: Effect of BMI on vessel contractility. Experimental traces showing the effect of 
U-46619 in a myometrial artery from (A) a normal weight woman and (B) a woman with 
BMI≥25 (BMI 29). (C) Mean concentration-response curves comparing the effect of U-
46619 in the normal weight (n=13), overweight (n=12) and obese (n=7) groups. Experimental 
traces showing the effect of AVP in a myometrial artery from (D) a normal weight woman 
and (E) a woman with BMI≥25 (BMI 36.3). (F) Mean concentration-response curves 
comparing the effect of AVP in the normal weight (n=15), overweight (n=8) and obese (n=3) 
groups.  
 
Figure 2: Effect of BMI on bradykinin-mediated relaxation. Mean concentration-response 
curves comparing the relaxatory effect of BK in vessels pre-contracted with (A) 10nM AVP 
(normal weight (n=10), overweight (n=7) and obese (n=6)), and (B) pre-contracted with 1µM 
U-46619 (normal weight (n=15), overweight (n=10) and obese (n=5)). 
 
Figure 3: Effect of BMI on carbachol-mediated relaxation. (A) Experimental trace from 
the myometrial artery of a normal weight woman (BMI<25) showing a relaxatory 
concentration-response curve to CCh (after pre-contraction with AVP). (B) Experimental 
trace from the myometrial artery of an overweight woman (BMI 26.3), showing no response 
to CCh, but normal relaxation to BK (after pre-contraction with AVP). (C) Bar chart 
demonstrating that the mean BMI of vessels that respond to CCh is significantly lower than 
the BMI of vessels that did not respond to CCh. (D) Graph demonstrating that the % of 
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vessels responding to CCh is related to maternal BMI. (E) Concentration-response curve for 
CCh in vessels from normal weight women.  
 
Figure 4: Effect of SNAP and MCD. (A) Experimental trace showing the relaxatory effect 
of SNAP (20µM) in myometrial arteries pre-contracted with AVP (BMI 26.3). (B) Bar chart 
demonstrating that SNAP produced a similar degree of relaxation in vessels from normal 
weight, overweight and obese women. (C) Concentration-response curves for BK in vessels 
from obese women (BMI>30) in the absence or presence of MCD.  
 
Figure 5: The role of eNOS in bradykinin-mediated relaxation. Effect of 100µM L-
NAME on AVP pre-contraction in vessels from (A) normal weight (n=6) and (B) BMI≥25 
women (n=5). Effect of L-NAME on the BK concentration-response curve in vessels from 
(C) normal weight (n=5-6) and (D) BMI≥25 (n=4-5) women. 
 
Figure 6: Confocal imaging of endothelial cell calcium responses. (A) Confocal image of 
myometrial artery endothelial cells (loaded with Cal-520) from a normal weight woman 
(BMI<25). (B) Experimental trace showing the effect of 10µM CCh and 1µM BK in one of 
the endothelial cells shown (BMI<25). (C & D) Experimental traces showing the effect of 
10µM CCh and 1µM BK in myometrial artery endothelial cells from women with BMI≥25. 
The Ca2+ response to BK can be transient (C) or sustained (D) in nature. 
 
Figure 7: Comparison of carbachol and bradykinin-mediated calcium responses. 
Amplitude of the Ca2+ response to BK in myometrial artery endothelial cells was 
significantly larger than the response to CCh in both normal weight (A) and BMI≥25 women 
(B). (C) A significantly larger proportion of myometrial artery endothelial cells from normal 
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weight women responded to BK with a rise in intracellular Ca2+ compared to CCh. (D) In 
myometrial arteries from women with BMI≥25, almost no endothelial cells responded to 
CCh, whereas most cells still responded to BK with a rise in intracellular Ca2+.  
 
 
Video legends 
Video file 1: Endothelial cell response to CCh and BK in a myometrial artery from a normal 
weight woman (BMI 22), loaded with the calcium-sensitive indicator Cal-520.The initial 
response seen is due to application of 10µM CCh and the subsequent larger calcium response 
it due to application of 1µM BK.  
Video file 2: Endothelial cell response to CCh and BK in a myometrial artery from a woman 
with BMI 29.9, loaded with the calcium-sensitive indicator Cal-520. 10µM CCh is applied at 
the beginning but no response is seen. When 1µM BK is applied (45s), a large endothelial 
cell response is observed.  
Video file 3: Endothelial cell response to SNAP in a myometrial artery from a normal weight 
woman, loaded with the calcium-sensitive indicator Cal-520. 20µM SNAP is applied from 5-
65s but no response is observed. 
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